 NEW YORK LONDON PARIS--BUSINESS WIRE--Regulatory News: Aptorum Group Limited Nasdaq: APM, Euronext Paris: APM a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced that Mr. Darren Lui, President and Executive Director of Aptorum Group will present virtually at the H.C. Wainwright Global Investment Conference being held on May 23-26, 2022. Aptorum Group management will be available and 